Medical News

RSS

Patients taking prescription opioids are at higher risk of developing mood disorders

People who are prescribed opioids for pain relief have a higher risk of developing mood disorders such as anxiety, University of Queensland researchers have found.

14 Mar 2022

UK Government to remove all COVID-19 international travel restrictions

The government will remove the remaining restrictions on international travel for all passengers ahead of the Easter holidays, the Transport Secretary announced today (14 March 2022).

14 Mar 2022

Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

A new study determined the humoral responses against SARS-CoV-2 in vaccinated hospital workers.

14 Mar 2022

Study rules out post-COVID-19 conditions in hospitalized patients in South Africa

Researchers conducted a longitudinal cohort observational study on SARS-CoV-2 patients for serial follow-up.

14 Mar 2022

Study evaluates efficacy of isotretinoin in improving COVID-19 outcomes

Researchers evaluated the effectiveness of isotretinoin (13-cis retinoic acid) in improving COVID-19 outcomes.

14 Mar 2022

Can wearables transform the future of healthcare?

In partnership with SLAS 2022, we spoke to Professor Michael Snyder about his latest research that investigates wearables and their future within healthcare.

From Society for Laboratory Automation and Screening (SLAS) 14 Mar 2022

KTU researchers improve an algorithm that detects Alzheimer's disease from MRI images

Lithuanian researchers from Kaunas University of Technology improved an algorithm that detects Alzheimer's disease from magnetic resonance imaging images.

14 Mar 2022

Study explores SARS-CoV-2 viremia kinetics

In a new study, researchers evaluated the kinetics of severe acute respiratory syndrome coronavirus-2 viremia.

14 Mar 2022

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

A new study assessed the neutralization induced by subunit vaccine boosters specific for the SARS-CoV-2 Omicron variant of concern.

14 Mar 2022

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

A new study investigated the broad-spectrum protection provided by hetero-bivalent nanobodies against SARS-CoV-2 variants of concern, such as Omicron.

14 Mar 2022

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Researchers analyze the available scientific evidence supporting vitamin D as a neuroprotective agent against the neurological sequelae of COVID-19.

14 Mar 2022

Conformational variation of the SARS-CoV-2 energy landscape

Researchers demonstrate that the energy landscape of SARS-CoV-2 exhibits significant conformational variation.

14 Mar 2022

Efficient inactivation of SARS-CoV-2 on N95 masks by an antimicrobial coating

In a recent study, researchers demonstrate that Goldshield75 coating inactivated SARS-CoV-2 on N95 filters and masks.

14 Mar 2022

COVID-19 incidence in K-12 schools in mask-required vs. mask-optional settings

Researchers evaluate the impact of wearing facemasks by students in schools and the incidence of SARS-CoV-2 infection.

14 Mar 2022

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Researchers assessed the impact of demographic variability on the Pfizer/BioNTech BNT162b2 vaccine-induced serological immunity against SARS-CoV-2 variants of concern and variants of interest.

14 Mar 2022

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

Scientists simulate different scenarios using facemasks through a computational Monte Carlo simulation model.

14 Mar 2022

Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

Researchers demonstrate enhanced loss-of-function editing of CRISPR/Cas9 in human cells.

14 Mar 2022

Role of carboxypeptidase U in severe COVID-19

A new study measured both proCPU and CPU+CPUi over time to determine the impact of SARS-CoV-2 infection on the CPU system.

14 Mar 2022

In silico screening of natural ACE2 inhibitors

Researchers identify potential ACE2 inhibitors through a virtual screening protocol.

14 Mar 2022

Neutralizing activity of therapeutic antibodies against clinical strains of BA.1 and BA.2 sub-lineages of the Omicron variant

Researchers conducted an in vitro analysis to assess the efficacy of monoclonal antibodies against the SARS-CoV-2 Omicron BA.2 and BA.1 variants.

14 Mar 2022

Medical News

Patients taking prescription opioids are at higher risk of developing mood disorders

UK Government to remove all COVID-19 international travel restrictions

Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

Study rules out post-COVID-19 conditions in hospitalized patients in South Africa

Study evaluates efficacy of isotretinoin in improving COVID-19 outcomes

Can wearables transform the future of healthcare?

KTU researchers improve an algorithm that detects Alzheimer's disease from MRI images

Study explores SARS-CoV-2 viremia kinetics

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Conformational variation of the SARS-CoV-2 energy landscape

Efficient inactivation of SARS-CoV-2 on N95 masks by an antimicrobial coating

COVID-19 incidence in K-12 schools in mask-required vs. mask-optional settings

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

Role of carboxypeptidase U in severe COVID-19

In silico screening of natural ACE2 inhibitors

Neutralizing activity of therapeutic antibodies against clinical strains of BA.1 and BA.2 sub-lineages of the Omicron variant

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News